Use of L-carnitine before percutaneous epididymal sperm aspiration-intracytoplasmic sperm injection for obstructive azoospermia.
- Author:
Shao-Ming LU
1
;
Xiao LI
;
Hao-Bo ZHANG
;
Jing-Mei HU
;
Jun-Hao YAN
;
Jiao-Long LIU
;
Zi-Jiang CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Azoospermia; therapy; Carnitine; administration & dosage; therapeutic use; Epididymis; Humans; Male; Sperm Injections, Intracytoplasmic; methods; Treatment Outcome
- From: National Journal of Andrology 2010;16(10):919-921
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the use of L-carnitine before percutaneous epididymal sperm aspiration-intracytoplasmic sperm injection (PESA-ICSI) in the treatment of obstructive azoospermia.
METHODSSeventy-nine cases of obstructive azoospermia treated in our center from Sep 2008 to Aug 2009 were divided into an L-carnitine (n = 43) and a control group (n = 36), the former given oral L-carnitine at 1 g bid for 3 months before PESA-ICSI, while the latter left untreated. Comparisons were made between the two groups in the number of retrieved oocytes and fertilized oocytes as well as the number and rate of good embryos.
RESULTSThere were no significant differences between the two groups in the number of retrieved oocytes and fertilized oocytes. But the number and rate of good embryos were significantly higher in the L-carnitine than in the control group (P < 0.05).
CONCLUSIONThree-month oral medication of L-carnitine before PESA-ICSI can raise the number and rate of good embryos in obstructive azoospermia patients and therefore benefit the therapeutic outcome.
